Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon ‐like peptide‐1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD‐4 substudy

ConclusionsIn combination with prandial lispro, treatment with dulaglutide and glargine resulted in similar proportions of glucose values in the normoglycaemic range, but dulaglutide provided an improved balance between the proportion of values within the near‐normoglycaemia range and values within the hypoglycaemic range.

Source: Diabetes, Obesity and Metabolism - July 21, 2016 Category: Endocrinology Authors: Johan Jendle, Marcia A. Testa, Sherry Martin, Honghua Jiang, Zvonko Milicevic Tags: ORIGINAL ARTICLE Source Type: research